Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Apr 28, 2026, 4:00 PM EDT
1.122
-0.008 (-0.74%)
After-hours: Apr 28, 2026, 7:46 PM EDT
Entera Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.04 | 0.18 | - | 0.13 | 0.57 | |
| Revenue Growth (YoY) | -76.80% | - | - | -76.53% | 56.44% | |
| Cost of Revenue | 0.04 | 0.17 | - | 0.1 | 0.37 | |
| Gross Profit | - | 0.01 | - | 0.03 | 0.2 | |
| Selling, General & Admin | 5.53 | 5.1 | 4.43 | 7.71 | 5.69 | |
| Research & Development | 6 | 4.5 | 4.51 | 5.85 | 6.77 | |
| Other Operating Expenses | - | - | -0.05 | -0.05 | -0.05 | |
| Operating Expenses | 11.53 | 9.59 | 8.89 | 13.51 | 12.42 | |
| Operating Income | -11.53 | -9.59 | -8.89 | -13.47 | -12.22 | |
| Interest & Investment Income | 0.09 | 0.06 | 0.03 | - | - | |
| Currency Exchange Gain (Loss) | - | - | - | - | -0.03 | |
| Other Non Operating Income (Expenses) | - | - | - | 0.08 | - | |
| EBT Excluding Unusual Items | -11.44 | -9.53 | -8.86 | -13.39 | -12.25 | |
| Other Unusual Items | - | - | - | 0.46 | - | |
| Pretax Income | -11.44 | -9.53 | -8.86 | -12.93 | -12.25 | |
| Income Tax Expense | - | 0.01 | 0.03 | 0.14 | -0.06 | |
| Net Income | -11.44 | -9.54 | -8.89 | -13.07 | -12.19 | |
| Net Income to Common | -11.44 | -9.54 | -8.89 | -13.07 | -12.19 | |
| Shares Outstanding (Basic) | 46 | 38 | 29 | 29 | 26 | |
| Shares Outstanding (Diluted) | 46 | 38 | 29 | 29 | 26 | |
| Shares Change (YoY) | 22.68% | 29.79% | 0.69% | 10.23% | 41.90% | |
| EPS (Basic) | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 | |
| EPS (Diluted) | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 | |
| Free Cash Flow | -7.48 | -6.82 | -7.33 | -12.55 | -9.08 | |
| Free Cash Flow Per Share | -0.16 | -0.18 | -0.25 | -0.44 | -0.35 | |
| Gross Margin | - | 4.97% | - | 24.63% | 34.68% | |
| Operating Margin | -27450.00% | -5295.58% | - | -10055.22% | -2139.58% | |
| Profit Margin | -27235.71% | -5271.27% | - | -9754.48% | -2134.33% | |
| Free Cash Flow Margin | -17802.38% | -3768.51% | - | -9362.69% | -1590.19% | |
| EBITDA | -11.5 | -9.54 | -8.84 | -13.41 | -12.16 | |
| D&A For EBITDA | 0.03 | 0.05 | 0.06 | 0.06 | 0.05 | |
| EBIT | -11.53 | -9.59 | -8.89 | -13.47 | -12.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.